These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metoclopramide-induced parkinsonism in hemodialysis patients. Report of two cases. Sirota RA; Kimmel PL; Trichtinger MD; Diamond BF; Stein HD; Yudis M Arch Intern Med; 1986 Oct; 146(10):2070-1. PubMed ID: 3767555 [TBL] [Abstract][Full Text] [Related]
3. Adverse neurologic effects of metoclopramide. Grimes JD; Hassan MN; Preston DN Can Med Assoc J; 1982 Jan; 126(1):23-5. PubMed ID: 7059869 [TBL] [Abstract][Full Text] [Related]
4. Metoclopramide-induced Parkinsonism. Clinical characteristics of ten cases. Indo T; Ando K Arch Neurol; 1982 Aug; 39(8):494-6. PubMed ID: 7103798 [TBL] [Abstract][Full Text] [Related]
5. [Severe parkinsonism due to metoclopramide: the importance of early recognition]. de Ronde MW; Kingma HJ; Munts AG Ned Tijdschr Geneeskd; 2013; 157(26):A6037. PubMed ID: 23835236 [TBL] [Abstract][Full Text] [Related]
7. [Severe parkinsonism due to metoclopramide in a patient with polypharmacy]. Hoogendam A; Hofmeijer J; Frijns CJ; Heeringa M; Schouten-Tjin a Tsoi SL; Jansen PA Ned Tijdschr Geneeskd; 2002 Jan; 146(4):175-7. PubMed ID: 11845569 [TBL] [Abstract][Full Text] [Related]
8. High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study. Tsai SC; Sheu SY; Chien LN; Lee HC; Yuan EJ; Yuan RY Br J Clin Pharmacol; 2018 Sep; 84(9):2000-2009. PubMed ID: 29745438 [TBL] [Abstract][Full Text] [Related]
9. Metoclopramide-induced movement disorders. Clinical findings with a review of the literature. Miller LG; Jankovic J Arch Intern Med; 1989 Nov; 149(11):2486-92. PubMed ID: 2684075 [TBL] [Abstract][Full Text] [Related]
10. [Incidence of parkinsonism after treatment with metoclopramide]. Ogawa N; Takayama H; Kuroda H; Ota Z; Yamamoto M Nihon Ronen Igakkai Zasshi; 1986 Sep; 23(5):453-6. PubMed ID: 3807025 [No Abstract] [Full Text] [Related]
11. Parkinsonism and tardive dyskinesia associated with long-term metoclopramide therapy. Grimes JD N Engl J Med; 1981 Dec; 305(23):1417. PubMed ID: 7300862 [No Abstract] [Full Text] [Related]
13. Metoclopramide-induced parkinsonism. Sandyk R S Afr Med J; 1983 May; 63(22):838. PubMed ID: 6857398 [No Abstract] [Full Text] [Related]
14. Asymmetry in clinical features of drug-induced parkinsonism. Sethi KD; Zamrini EY J Neuropsychiatry Clin Neurosci; 1990; 2(1):64-6. PubMed ID: 1983774 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Ganzini L; Casey DE; Hoffman WF; McCall AL Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437 [TBL] [Abstract][Full Text] [Related]
16. Metoclopramide-induced parkinsonism and severe edema. Ahmad S South Med J; 1984 Oct; 77(10):1345. PubMed ID: 6484665 [No Abstract] [Full Text] [Related]
17. Metoclopramide-induced encephalopathy in Parkinson disease. Robottom BJ; Shulman LM; Anderson KE; Weiner WJ South Med J; 2010 Feb; 103(2):178-80. PubMed ID: 20065895 [TBL] [Abstract][Full Text] [Related]